Patient Says He Offered Thousands Out of Pocket for a Psoriasis Biologic
A psoriasis patient offered thousands out of pocket for risankizumab before his dermatologist redirected him to Medicare-covered tildrakizumab. His account puts cost at the center of shared decision-…